Document is current

Article History

Received: 6 May 2018

Accepted: 29 July 2018

First Online: 15 August 2018

Ethics approval and consent to participate

: The study was approved by the institutional review board of the medical department Würzburg (20,170,904 01; 220/15_z). Informed oral and written consent had been obtained of all patients.

: All patients gave written informed consent for participation in the study and publication of the study’s results.

: DO received speaker’s honoraria from Sanofi-Genzyme and travel assistance from Sanofi-Genzyme and Shire. JM received travel assistance from Sanofi-Genzyme, Shire and Amicus. PN received travel assistance, speaker’s/advisory board honoraria, and research support from Amicus, Sanofi-Genzyme and Shire. CW received travel assistance, speaker’s/advisory board honoraria, and research support from Actelion, Protalix, Sanofi-Genzyme and Shire. The other authors declare no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.